Aerovate Therapeutics
AVTE
#9169
Rank
C$0.10 B
Marketcap
$3.64
Share price
0.00%
Change (1 day)
-86.89%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$15.03 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are C$15.03 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$11.61 M209.41%
2021-12-31C$3.75 M-83.7%
2020-12-31C$23.02 M146.34%
2019-12-31C$9.34 M